Thea Bätz provides an overview of systemic treatment options for patients with advanced hepatocellular carcinoma (HCC)
Thea Bätz provides an overview of systemic treatment options for patients with advanced hepatocellular carcinoma (HCC)
Thea Bätz works as study coordinator in the outpatient department for hepatocellular carcinomas at the Johannes Gutenberg University in Mainz. In this function, she cares for study patients and outpatients. After completing her training, she worked for 18 years as a children’s nurse at the University Hospital in Lübeck. Since 2000 Thea Bätz has been working at the University Medical Center Mainz, where she first worked in cardiology and GI oncology. She completed her training as a study assistant and has been working in the HCC area since the SHARP Trial. Due to the close cooperation within the study office she is also involved in the GI oncology area. In recent years, she has participated in several projects on practical work with oncological patients, taking into consideration international differences.
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer
Maximising outcomes for patients with advanced RCC
Medical experts make recommendations for best practice
The latest non-small cell lung cancer data presented at ASCO
GI oncologists review the latest data presented at ASCO 2024
Medical experts discuss the latest learnings from clinical practice